Clinwas Gel Topico Pregnancy

• Pregnancy of Clinwas Gel Topico in details
• Clinwas Gel Topico breastfeeding
• Clinwas Gel Topico reviews

Pregnancy of Clinwas Gel Topico in details

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1^st trimester (and there is no evidence of a risk in later trimesters).

Clinwas Gel Topico breastfeeding

Use is not recommended; an alternate drug may be preferred Excreted into human milk: Yes Comments: Infants should be monitored for side effects on the gastrointestinal flora, such as diarrhea, candidiasis (thrush, diaper rash), or rarely, blood in the stool.

A report of bloody stools in a 5-day-old breastfed infant may have been caused by the concurrent maternal administration of IV Clinwas Gel Topico and gentamicin. Symptoms resolved 24 hours after breastfeeding was stopped and no further difficulties reported when breastfeeding was resumed on day 6 of age, after the maternal antibiotics were stopped. Concentrations in breast milk after oral administration of Clinwas Gel Topico 150 mg orally three times a day after at least 1 week of therapy have been reported at 1.2 mg/L (average, 6 hours after dosing) and at 0.3 to 1.2 mg/L between one and 6 hours after a single 150 mg dose. Peak concentrations in breast milk after oral dosing of 300 mg every six hours have been reported at 1.3 mg/L after 3.5 hours and 1.8 mg/L after 2 hours. Peak concentrations in breast milk after IV administration of Clinwas Gel Topico 600 mg IV every six hours have been reported at 2.65 mg/L after 3.5 hours and 3.1 mg/L after 30 minutes.

See references

References for pregnancy information

1. Ugwumadu A, Manyonda I, Reid F, Hay P "Effect of early oral Clinwas Gel Topico on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial." Lancet 361 (2003): 983-8
2. Cerner Multum, Inc. "Australian Product Information." O 0
3. "Product Information. Cleocin (Clinwas Gel Topico)." Pharmacia and Upjohn, Kalamazoo, MI.
4. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

References for breastfeeding information

1. Roberts RJ, Blumer JL, Gorman RL, et al "American Academy of Pediatrics Committee on Drugs: Transfer of drugs and other chemicals into human milk." Pediatrics 84 (1989): 924-36
2. Department of Adolescent and Child Health and Development. UNICEF. World Health Organization "Breastfeeding and maternal medication: recommendations for drugs in the eleventh Who model list of essential drugs. Available from: URL: http://whqlibdoc.who.int/hq/2002/55732.pdf?ua=1" ():
3. Smith JA, Morgan JR, Rachlis AR, Papsin FR "Clinwas Gel Topico in human breast milk." Can Med Assoc J 112 (1975): 806
4. "Product Information. Cleocin (Clinwas Gel Topico)." Pharmacia and Upjohn, Kalamazoo, MI.
5. Mann CF "Clinwas Gel Topico and breast-feeding." Pediatrics 66 (1980): 1030-1
6. Cerner Multum, Inc. "Australian Product Information." O 0
7. Matsuda S "Transfer of antibiotics into maternal milk." Biol Res Pregnancy Perinatol 5 (1984): 57-60
8. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):
9. Steen B, Rane A "Clinwas Gel Topico passage into human milk." Br J Clin Pharmacol 13 (1982): 661-4

References

1. PubMed Health. "Clindamycin (Into the vagina) (Cleocin Vaginal): This section provide the link out information of drugs collectetd in PubMed Health. ". http://www.ncbi.nlm.nih.gov/pubmedhe... (accessed September 17, 2018).
2. FDA Pharm Classes. "FDA Pharmacological Classification: FDA published a final rule that amended the requirements for the content and format of approved labeling (prescribing information) for human prescription drug and biological products in January 2006.". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).
3. LiverTox. "Clindamycin: LIVERTOX provides up-to-date, accurate, and easily accessed information on the diagnosis, cause, frequency, patterns, and management of liver injury attributable to prescription and nonprescription medications, herbals and dietary supplements. ". https://livertox.nlm.nih.gov//Clinda... (accessed September 17, 2018).

Reviews

Consumer reviews

Information checked by Dr. Sachin Kumar, MD Pharmacology